Skip to main content

Table 3 Total mass removal rate, Mass adsorption rate, Sieving coefficient, and Plasma clearance of NGAL during CVVH

From: The effect of continuous venovenous hemofiltration on neutrophil gelatinase-associated lipocalin plasma levels in patients with septic acute kidney injury

 

T0

T2

T4

T8

T12

Ci (ng/mL)

879 (733, 1466)

850 (685, 1525)

859 (688, 1496)

847 (689, 1417)

844 (694, 1405)

Co (ng/mL)

867 (697, 1451)

845 (703, 1332)

890 (661, 1416)

834 (689, 1326)

819 (646, 1415)

Cuf (ng/mL)

32.2 (26.7, 40.8)

30.3 (23.6, 34.9)

27.7 (24.1, 31.9)

26.1 (21.2, 30.1)

24.0 (20.1, 28.0)

Mi (μg/min)

107 (94, 183)

104 (97, 194)

105 (89, 197)

105 (91, 182)

110 (88, 180)

Mo (μg/min)

104 (92, 181)

107 (88, 170)

109 (85, 182)

107 (89, 170)

109 (85, 172)

Muf (ng/min)

2189 (1330, 2748)

1807 (1181, 3363)

1888 (1309, 2312)

2048 (1129, 3693)

1397 (1018, 3471)

Mtr (ng/min)

1430 (239, 4914)

1502 (−2500, 4801)

3240 (593, 5544)

3024 (−82, 5360)

4620 (2540, 6687)

Mad (ng/min)

−313(−2576, 3470)

−1369 (−5611, −1682)

1651 (−1494, 3308)

354 (−2195, 3201)

2216 (507, 5104)

SC

0.21 (0.17, 0.26)

0.19 (0.16, 0.22)

0.17 (0.15, 0.21)

0.16 (0.13, 0.20)

0.16 (0.12, 0.18)

Clearance

2.05 (0.39, 3.57)

1.45 (−3.15, 4.28)

3.74 (0.73, 6.09)

3.56 (−0.45, 5.80)

4.57 (1.85, 8.94)

  1. Data are presented as median (25th, 75th percentiles). CVVH continuous venovenous hemofiltration, NGAL neutrophil gelatinase-associated lipocalin, Ci concentration in inlet plasma before addition of replacement fluid, Co concentration in outlet plasma, Cuf concentration in the ultrafiltrate, Mad mass adsorption rate, Muf mass ultrafiltration rate, Mi mass inlet rate, Mo mass outlet rate, Mtr mass removal rate, SC sieving coefficient